IONTAS
IONTAS is a Cambridge, UK-based private antibody discovery and engineering services firm serving pharmaceutical and biotech clients. It offers end-to-end antibody R&D using proprietary mammalian display technology, yeast display, and custom antibody libraries, plus cryo-EM structural analysis.
- Company typePrivate
- Founded2012
- HeadquartersCambridge, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingServices
IONTAS firmographics
Firmographics- Name
- IONTAS
- Legal name
- Iontas Limited
- Website
- https://iontas.co.uk
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- IONTAS is a Cambridge, UK-based private antibody discovery and engineering services firm serving pharmaceutical and biotech clients. It offers end-to-end antibody R&D using proprietary mammalian display technology, yeast display, and custom antibody libraries, plus cryo-EM structural analysis.
- Ownership category
- akta.pro rank
IONTAS industry classification
Industry- Product category
- Biologics Contract Research Services
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)
- akta.pro secondary industries
- Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC), Protein Interaction & Structural Biology Platforms (cryo-EM, X-ray, NMR, biophysics) (HLAAAIAH), High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA), Engineered Protein Therapeutics (de novo/AI-designed proteins, novel scaffolds) (HLAAAAAJ)
Keywords
Where IONTAS is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
IONTAS business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Distribution channels1 record
Marketing channels3 records
IONTAS product offering
Product offeringCore offering
IONTAS delivers antibody discovery and engineering services to pharmaceutical and biotechnology clients, using proprietary mammalian display alongside phage and yeast display platforms to identify and optimize therapeutic antibodies. Its integrated pipeline spans antibody library construction, hit selection, affinity maturation, protein production, functional and biophysical characterization, stable cell line development, sample logistics (biologistics), and high-resolution cryo-EM structural analysis.
Differentiator
Problem solved
Functional benefit
Products and services
- Antibody Discovery Comprehensive service for identifying and selecting therapeutic antibodies from large libraries using advanced display technologies (phage, mammalian, and yeast display).
- Antibody Engineering Service for modifying antibody properties including affinity, stability, and effector function to optimize therapeutic candidates for pharmaceutical and biotech clients.
- Protein Production Service for expressing and purifying recombinant proteins for research and therapeutic development purposes.
- Functional Analysis Service for characterizing antibody biological activity and functional properties through various assay formats.
- Biophysical Characterization Service for analyzing protein structure and physical properties including thermal stability and binding kinetics.
- Cell Line Services Comprehensive service for generating and banking stable cell lines for antibody production.
- Cell Line Engineering Service for engineering cell lines to enhance productivity and product quality for biomanufacturing.
- Cell Line Development Service for developing stable cell lines optimized for high-yield production of therapeutic antibodies.
- Biologistics Service for managing biological sample logistics and supply chain for antibody development programs.
- Cryo-EM Cryo-electron microscopy service for high-resolution structural analysis of proteins and antibodies.
- Mammalian Display Proprietary display technology platform using mammalian cells for antibody selection and optimization, enabling proper protein folding and post-translational modifications.
- Explorer Libraries Proprietary antibody library platform for exploring sequence space and identifying therapeutic candidates.
- Yeast Display Yeast-based display platform for antibody engineering and affinity maturation.
- Superhuman Libraries Advanced antibody library platform designed to mimic human antibody diversity for therapeutic development.
Companies that use IONTAS
Customer profileSegments1 record
Ideal customer profiles1 record
IONTAS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
IONTAS competitors and assessment
Company assessmentOthers
- Aldevron: Provides protein, plasmid, and biologics production/services supporting antibody development, adjacent to IONTAS's protein production and cell line services.
Direct peers
- Creative Biolabs: Offers antibody discovery, engineering, and production services across multiple display platforms to biopharma, overlapping IONTAS's full service menu.
- Isogenica: UK-based antibody and peptide display discovery company using proprietary library/display technologies, directly comparable in platform and geography.
- Adimab: Antibody discovery and engineering platform company serving pharma/biotech; directly comparable in offering display/yeast-based discovery services for therapeutic antibodies.
- Abzena: Provides antibody engineering, protein production, and biologics development services to biopharma, closely overlapping IONTAS's discovery-to-development offering.
- Absolute Antibody: Specialist in recombinant antibody engineering, production, and characterization services, closely matching IONTAS's engineering and protein production offerings.
- FairJourney Biologics: Integrated antibody discovery and production CRO that IONTAS operates within/alongside; identical service scope from discovery through cell line development.
Emerging players
- Twist Biopharma: Offers synthetic antibody libraries and discovery services leveraging DNA synthesis, competing in the library-based antibody discovery segment.
- OmniAb (Ligand): Antibody discovery platform licensing display/animal-based technologies to drug developers, comparable in providing differentiated antibody discovery capabilities.
Broad incumbents
- Distributed Bio (Charles River): Charles River's antibody discovery unit offers display-based discovery and engineering services as part of a broad CRO portfolio, competing directly in antibody discovery.
Market position
Customer concentration
IONTAS social profiles
Digital presenceIONTAS financial estimates
Financial estimateRevenue estimate
Valuation estimate
IONTAS leadership team
Management profileNumber of profiles
IONTAS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IONTAS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IONTAS
What does IONTAS do?
IONTAS delivers antibody discovery and engineering services to pharmaceutical and biotechnology clients, using proprietary mammalian display alongside phage and yeast display platforms to identify and optimize therapeutic antibodies. Its integrated pipeline spans antibody library construction, hit selection, affinity maturation, protein production, functional and biophysical characterization, stable cell line development, sample logistics (biologistics), and high-resolution cryo-EM structural analysis.
Is IONTAS a public or private company?
IONTAS is a private company. It is classified as unknown and is currently operating.
When was IONTAS founded?
IONTAS was founded in 2012. It employs 1 to 10 people.
Where is IONTAS based?
IONTAS is headquartered in Cambridge, United Kingdom, in the Europe region.
Who are IONTAS's main competitors?
Aldevron is listed as an others. Direct peers are Creative Biolabs, Isogenica, Adimab, Abzena, Absolute Antibody and FairJourney Biologics. Emerging players are Twist Biopharma and OmniAb (Ligand). Distributed Bio (Charles River) is listed as a broad incumbent.
Does IONTAS have an API?
No public API is recorded for IONTAS.
What industry is IONTAS in?
IONTAS's product category is Biologics Contract Research Services. Its primary akta.pro industry code is HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering), with a secondary code of HLAAAIAC, Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization). Its NAICS code is 325414 and its SIC code is 8731.